ONCAlert | 2018 ASCO Annual Meeting

Chronic Lymphocytic Leukemia MORE >>

While the approval of new agents represents a great step forward in the treatment of chronic lymphocytic leukemia (CLL), physicians are now challenged with how to best utilize these new treatment options, according to a presentation by Anthony Mato, MD, MSCE, at the 2nd Annual Live Medical Crossfire: Hematologic Malignancies.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.